No Data
KeyBanc Maintains HCA Healthcare(HCA.US) With Buy Rating, Cuts Target Price to $370
KeyBanc Remains a Buy on HCA Healthcare (HCA)
Press Release: HCA Healthcare, Inc. 4th Quarter 2024 Earnings Conference Call
Express News | HCA Healthcare, Inc. 4TH Quarter 2024 Earnings Conference Call
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock